Moreover, we utilized platforms like Research Gate, academic.oup.com, and Encyclopedia.pub, which foster intellectual discourse
New research links GLP-1 agonists, even in lower doses, to improved mood in certain patients with depressive disorders, as well as potential cognitive benefits in people with dementia or Alzheimers
Andrew Huberman: It's like, "If it's done in mice, great, I'll try it." Other people say, "No, it has to be done in humans, double blind, placebo-controlled studies, randomized clinical trials, et cetera." Then other people are
It might cover GLP-1 drugs when theyre prescribed for weight loss, as it wouldnt have the same statutory prohibition that applies to Part D coverage
Together, all these biochemical facts represent a mechanistic construal reflecting a solid scaffold for the alleged beneficial cardiovascular outcomes obtained by inhibition of DPP4 activity
Elucidating mechanisms of action in relation to cardiorenal protection Questions remain about the mechanism of action of SGLT2 inhibitors and GLP-RAs, particularly in relation to the cardiorenal benefits observed in some diabetes CVOTs [110,111,112] (Additional file 2: Fig